1. Progress of long non-coding RNA in pituitary adenoma
Jinke DING ; Chenglong LI ; Henglu WANG ; Zefu LI
Cancer Research and Clinic 2020;32(1):69-72
Pituitary adenoma is a common neuroendocrine tumor, and its complex pathogenesis makes its treatment a clinical problem. Recently, studies have shown that long non-coding RNA (LncRNA), as a class of endogenous RNA with a length of more than 200 nucleotides and basically no protein-coding function, plays an important regulatory role in various forms in multiple tumors including pituitary adenoma, and is closely related to the proliferation, invasion and metastasis of pituitary adenoma. Based on the latest research status at home and abroad, this paper summarizes the research progress of LncRNA in pituitary adenoma, hoping to provide new ideas for the diagnosis, treatment and prognosis of pituitary adenoma.
2.Recent advance in interventional embolization for chronic subdural hematoma
Henglu WANG ; Chao WANG ; Zhenzhu LI ; Wenhu XU ; Chenglong LI ; Jinke DING ; Ganxian FAN ; Zefu LI
Chinese Journal of Neuromedicine 2020;19(5):528-531
Chronic subdural hematoma (cSDH) occurs in acute subdural hemorrhage after head trauma or converts from effusion. Traditional treatment is based on conservative treatment and surgical drainage. The effective rate of conservative treatment is only 3%-18%; even with drilling drainage treatment, the recurrence rate is as high as 33%. Recently, the middle meningeal artery embolization technique based on pathological analysis can greatly reduce the recurrence rate, and the operation is simple and curative effect is exact. This article reviews the pathogenesis of cSDH and progress of interventional therapy.